Cellular and humoral responses to Leishmania major virulence factors in healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients

Clinical and Vaccine Immunology

Volumn 16, Issue 6, 2009, Pages 956-958

  Lakhal Naouar, Inès ^a   Boussoffara, Thouraya ^a   Meddeb Garnaoui, Amel ^a   Achour Chenik, Yosser Ben ^a   Louzir, Hechmi ^a   Chenik, Mehdi ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN DISULFIDE ISOMERASE; PROTOZOAL PROTEIN; VIRULENCE FACTOR;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL EVALUATION; CONTROLLED STUDY; HUMAN; HUMORAL IMMUNITY; INTERFERON PRODUCTION; LEISHMANIA MAJOR; LYMPHOCYTE PROLIFERATION; PARASITE VIRULENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; CELL PROLIFERATION; CELLS, CULTURED; CHILD, PRESCHOOL; HUMANS; INFANT; INTERFERON-GAMMA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; LEUKOCYTES, MONONUCLEAR; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEIN DISULFIDE-ISOMERASES; PROTOZOAN PROTEINS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 67249117347     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00023-09     Document Type: Article

References (15)

1. Azeredo-Coutinho, R. B., D. C. Matos, G. G. Armoa, R. M. Maia, A. Schubach, W. Mayrink, and S. C. Mendonca. 2008. Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization. Clin. Exp. Immunol. 153:369-375.
2. Ben Achour, Y., M. Chenik, H. Louzir, and K. Dellagi. 2002. Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor. Infect. Immun. 70:3576-3585.
3. Bousoffara, T., H. Louzir, A. Ben Salah, and K. Dellagi. 2004. Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis. J. Infect. Dis. 189:1265-1273.
4. Chappuis, F., S. Rijal, U. K. Jha, P. Desjeux, B. M. Karki, S. Koirala, L. Loutan, and M. Boelaert. 2006. Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. Trop. Med. Int. Health 11:31-40.
5. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
6. Fernandes, A. P., M. M. Costa, E. A. Coelho, M. S. Michalick, E. de Freitas, M. N. Melo, W. Luiz Tafuri, M. Resende, V. Hermont, F. Abrantes, and R. T. Gazzinelli. 2008. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 26:5888-5895.
7. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
8. Jaafari, M. R., A. Ghafarian, A. Farrokh-Gisour, A. Samiei, M. T. Kheiri, F. Mahboudi, F. Barkhordari, A. Khamesipour, and W. R. McMaster. 2006. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Vaccine 24:5708-5717. (Pubitemid 43928184)
9. Khoshgoo, N., F. Zahedifard, H. Azizi, Y. Taslimi, M. J. Alonso, and S. Rafati. 2008. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals. Vaccine 26:5822-5829.
10. Kuhn, D., and M. Wiese. 2005. LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation. Mol. Microbiol. 56:1169-1182.
11. Pedras, M. J., L. de Gouvea Viana, E. J. de Oliveira, and A. Rabello. 2008. Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 102:172-178.
12. Reithinger, R., J. C. Dujardin, H. Louzir, C. Pirmez, B. Alexander, and S. Brooker. 2007. Cutaneous leishmaniasis. Lancet Infect. Dis. 7:581-596.
13. Resende, D. M., B. C. Caetano, M. S. Dutra, M. L. Penido, C. F. Abrantes, R. M. Verly, J. M. Resende, D. Pilo-Veloso, S. A. Rezende, O. Bruna-Romero, A. P. Fernandes, and R. T. Gazzinelli. 2008. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells. Vaccine 26:4585-4593.
14. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2:845-858.
15. Schallig, H. D., G. J. Schoone, C. C. Kroon, A. Hailu, F. Chappuis, and H. Veeken. 2001. Development and application of 'simple' diagnostic tools for visceral leishmaniasis. Med. Microbiol. Immunol. 190:69-71.